&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-02-10, 16:00

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-02-06, 15:00

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-02-04, 15:00

Beltone Debuts Latest Hearing Innovations with Beltone Envision(TM) Hearing Aids –The World’s Best Technology for Hearing in Noise And New Auracast Assistant
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-21, 18:45

Descartes Study: 74% of Supply Chain Leaders See Technology as Key to Growth Amid Rising Global Trade Complexities
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-14, 21:00

81% of CDP users gain competitive edge in AI initiatives, Tealium research shows
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-09, 19:30

Constellation Brands Declares Quarterly Dividend
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-12-26, 22:46

Bitget to Merge BGB and BWB Tokens, Advancing a Unified Onchain Ecosystem
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-12-12, 20:30

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-22, 14:30

Heilind Asia Pacific Awarded 2024 “Best Strategic Account Development” by TE Connectivity
Tony Loman

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-20, 19:00

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
Tony Loman

Popular Posts